Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
69.65
-0.28 (-0.40%)
At close: Oct 29, 2025, 4:00 PM EDT
69.60
-0.05 (-0.07%)
Pre-market: Oct 30, 2025, 4:04 AM EDT

Avidity Biosciences Stock Forecast

Stock Price Forecast

The 19 analysts that cover Avidity Biosciences stock have a consensus rating of "Buy" and an average price target of $69.26, which forecasts a -0.56% decrease in the stock price over the next year. The lowest target is $55 and the highest is $96.

Price Target: $69.26 (-0.56%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$55$69.26$72$96
Change-21.03%-0.56%+3.37%+37.83%

Analyst Ratings

The average analyst rating for Avidity Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy677794
Buy677887
Hold000009
Sell000000
Strong Sell000000
Total121414151720

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Hold
Downgrades
$78$74
HoldDowngrades$78$74+6.25%Oct 29, 2025
Chardan Capital
Chardan Capital
Hold
Downgrades
$75$72
HoldDowngrades$75$72+3.37%Oct 28, 2025
RBC Capital
RBC Capital
Hold
Downgrades
$61$72
HoldDowngrades$61$72+3.37%Oct 28, 2025
Citigroup
Citigroup
Hold
Downgrades
$75$72
HoldDowngrades$75$72+3.37%Oct 27, 2025
Leerink Partners
Leerink Partners
Hold
Downgrades
$65$72
HoldDowngrades$65$72+3.37%Oct 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
9.43M
from 10.90M
Decreased by -13.43%
Revenue Next Year
19.65M
from 9.43M
Increased by 108.26%
EPS This Year
-4.49
from -2.89
EPS Next Year
-4.94
from -4.49
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.79M9.33M9.22M9.56M10.90M9.43M19.65M
Revenue Growth
192.67%37.41%-1.09%3.64%13.99%-13.43%108.26%
EPS
-2.05-2.85-3.34-2.91-2.89-4.49-4.94
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1818
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High14.1M68.7M
Avg9.4M19.6M
Low4.9Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High
29.2%
628.0%
Avg
-13.4%
108.3%
Low
-55.0%
-

EPS Forecast

EPS20252026202720282029
High-3.50-3.40
Avg-4.49-4.94
Low-6.13-7.17

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.